Scientific Advisory Board
DATE : August 4-7, 2008
VENUE : World Trade Center Boston and The Seaport Hotel Boston, MA
Drug Discovery & Development of Innovative Therapeutics 2008 Scientific Advisory Board
Joseph B. Bolen, Ph.D., Chief Scientific Officer, Millennium Pharmaceuticals
Illana Gozes, Ph.D., Chief Scientific Officer, Allon Therapeutics
Brian Hubbard, Ph.D., Diabetes and Metabolism, Novartis Institutes for BioMedical Research
Jason Kim, Ph.D., Associate Professor, Cellular & Molecular Physiology, Pennsylvania State University College of Medicine
Alan Louie, Ph.D., Research Director, Health Industry Insights, IDC
Rose A. Maciewicz, Ph.D., Chief Scientist, Respiratory and Inflammation Research Area, AstraZeneca, United Kingdom
Michael McCully, Director & Senior Analyst, Recombinant Capital, Inc.
Matthew Pando, Ph.D., Vice President, R&D, ExonHit Therapeutics
David J. Payne, Director and Head of Microbiology, Infectious Diseases Center of Excellence for Drug Discovery (CEDD), GlaxoSmithKline
Norton P. Peet, Ph.D., Pharmaceutical Industry Consultant
Georg C. Terstappen, Ph.D., Vice President, Discovery Research, Siena Biotech, Italy
Chengbin Wu, Ph.D., Senior Scientist and Project Leader, Abbott Bioresearch
|
